Skip to Content

N 343 2.5 (Glyburide 2.5 mg)

Pill with imprint N 343 2.5 is Orange, Round and has been identified as Glyburide 2.5 mg. It is supplied by Teva Pharmaceuticals USA.

Glyburide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glyburide 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for N 343 2.5

Glyburide 2.5 mg N 343 2.5
Glyburide 2.5 mg N 343 2.5 Front
Glyburide 2.5 mg N 343 2.5 Back
Glyburide 2.5 mg N 343 2.5 Front
Glyburide 2.5 mg N 343 2.5 Back
Glyburide 2.5 mg N 343 2.5
Glyburide 2.5 mg N 343 2.5

Glyburide

Imprint
N 343 2.5
Strength
2.5 mg
Color
Orange
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Sulfonylureas
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
microcrystalline cellulose, corn starch, sodium starch glycolate type A potato, silicon dioxide, magnesium stearate, FD&C Yellow No. 6, aluminum oxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-8343 Teva Pharmaceuticals USA, Inc.
51079-0872 UDL Laboratories Inc.
42291-0316 AvKare, Inc.
35356-0360 Lake Erie Medical and Surgical Supply (repackager)
55289-0606 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.